Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'VINORELBINE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 442 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Bonfil, RD; Gonzalez, AD; Siguelboim, D; Carrion, FDC; Ciocca, DR; Villaronga, A; Metz, L; Mosso, F; Fayad, E; Reale, M; Schmilovich, AJ
      Immunohistochemical analysis of Ki-67, p21(waf1/cip1) and apoptosis in marker lesions from patients with superficial bladder tumours treated with vinorelbine intravesical therapy in a preliminary phase I trial

      BJU INTERNATIONAL
    2. Ragot, S; Sauvage, FL; Rousseau, A; Genet, D; Dupuy, JL; Tubiana-Mathieu, N; Marquet, P
      Sensitive determination of vinorelbine and its metabolites in human serum using liquid chromatography-electrospray mass spectrometry

      JOURNAL OF CHROMATOGRAPHY B
    3. Fahy, J
      Modifications in the "upper" or velbenamine part of the Vinca alkaloids have major implications for tubulin interacting activities

      CURRENT PHARMACEUTICAL DESIGN
    4. Hill, BT
      Vinflunine, a second generation novel Vinca alkaloid with a distinctive pharmacological profile, now in clinical development and prospects for futuremitotic blockers

      CURRENT PHARMACEUTICAL DESIGN
    5. Han, JY; Choi, BG; Song, DH; Ahn, JG; Yoon, JS; Lee, KS
      Vinorelbine-associated myelopathy in a patient who previously received paclitaxel - A case report

      MEDICAL ONCOLOGY
    6. Harries, M; Kaye, SB
      Recent advances in the treatment of epithelial ovarian cancer

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    7. Brown, RE; Hutton, J; Burrell, A
      Cost effectiveness of treatment options in advanced breast cancer in the UK

      PHARMACOECONOMICS
    8. Landini, I; Bartolozzi, B; Banchelli, I; Innocenti, AD; Nocentini, O; Bernabei, PA
      In vitro activity of vinorelbine on human leukemia cells

      JOURNAL OF CHEMOTHERAPY
    9. Tognoni, A; Pensa, F; Vaira, F; Vigani, A; Bancalari, L; Fiasella, L; Maggiani, R; Canessa, P; Pronzato, P
      A three-drug regimen (gemcitabine, ifosfamide and cisplatin) for advanced non-small-cell lung cancer

      JOURNAL OF CHEMOTHERAPY
    10. Nishizaki, M; Meyn, RE; Levy, LB; Atkinson, EN; White, RA; Roth, JA; Ji, L
      Synergistic inhibition of human lung cancer cell growth by adenovirus-mediated wild-type p53 gene transfer in combination with docetaxel and radiation therapeutics in vitro and in vivo

      CLINICAL CANCER RESEARCH
    11. Kruczynski, A; Hill, BT
      Vinflunine, the latest Vinca alkaloid in clinical development - A review of its preclinical anticancer properties

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    12. Brugnatelli, S; Riccardi, A; Danova, M; Pugliese, P; Tinelli, C; Luchena, G; Bernardo, A; Giardina, G; Fava, S; Montanari, G; Pedrotti, C; Poli, AM
      Sequential docetaxel and vinorelbine for patients with advanced breast cancer previously treated with anthracyclines: A phase II study

      ONCOLOGY REPORTS
    13. Bretti, S; Manzin, E; Celano, A; Ritorto, G; Loddo, C; Berruti, A
      Low dose carboplatin (AUC 4.5) combined with vinorelbine in the treatment of advanced non-small cell lung cancer: A single institution phase II study

      ONCOLOGY REPORTS
    14. Danova, M; Porta, C; Ferrari, S; Riccardi, A
      Strategies of medical treatment for metastatic breast cancer

      INTERNATIONAL JOURNAL OF ONCOLOGY
    15. Weiss, AJ; Lackman, RD
      Concurrent administration of vinorelbine with human recombinant granulocyte-macrocyte stimulating factor

      INTERNATIONAL JOURNAL OF ONCOLOGY
    16. Kosmas, C; Tsavaris, N; Panopoulos, C; Vadiaka, M; Stavroyianni, N; Kourelis, T; Malamos, N; Antonopoulos, M; Kalofonos, HP
      Gemcitabine and vinorelbine as second-line therapy in non-small-cell lung cancer after prior treatment with taxane plus platinum-based regimens

      EUROPEAN JOURNAL OF CANCER
    17. Laack, E; Mende, T; Benk, J; Chemaissani, A; Scholtze, J; Lorenz, C; Niestroy, A; Dalhoff, K; Muller, T; Walter, T; Durk, H; Edler, L; Hossfeld, DK
      Gemcitabine and vinorelbine as first-line chemotherapy for advanced non-small cell lung cancer: a phase II trial

      EUROPEAN JOURNAL OF CANCER
    18. Baron, F; Cueva, J; Grana, B; Curiel, T; Leon, L; Vazquez, F; Candamio, S; Lopez, R
      Gemcitabine plus vinorelbine for the treatment of advanced non-small cell lung cancer

      EUROPEAN JOURNAL OF CANCER
    19. Giaccone, G
      State of the art in systemic treatment of lung cancer

      EUROPEAN JOURNAL OF CANCER
    20. Li, N; van Agthoven, M; Willemse, PHB; Uyl-de Groot, CA
      A cost-utility analysis comparing second-line chemotherapy schemes in patients with metastatic breast cancer

      ANTI-CANCER DRUGS
    21. Green, MR
      The current status of docetaxel for advanced non-small cell lung cancer

      ANTI-CANCER DRUGS
    22. Vassilomanolakis, M; Koumakis, G; Barbounis, V; Orphanos, G; Efremidis, A
      Prevention of vinorelbine phlebitis with cimetidine - A two-step design study

      SUPPORTIVE CARE IN CANCER
    23. Marti, JL; Bueso, P; Mayordomo, JI; Isla, MD; Saenz, A; Escudero, P; Murillo, L; Filipovich, E; Andres, R; Tres, A
      Combination chemotherapy with docetaxel plus vinorelbine in metastatic breast cancer patients with prior exposure to anthracyclines

      ANNALS OF ONCOLOGY
    24. Campone, M; Fumoleau, P; Delecroix, V; Deporte-Fety, R; Perrocheau, G; Vernillet, L; Borg-Olivier, O; Louboutin, JP; Bissery, MC; Riva, A; Azli, N
      Phase I dose-finding and pharmacokinetic study of docetaxel and vinorelbine as first-line chemotherapy for metastatic breast cancer

      ANNALS OF ONCOLOGY
    25. Vermorken, JB; Zanetta, G; Oliveira, CFD; van der Burg, MEL; Lacave, AJ; Teodorovic, I; Boes, GH; Colombo, N
      Randomized phase III trial of bleomycin, vindesine, mitomycin-C, and cisplatin (BEMP) versus cisplatin (P) in disseminated squamous-cell carcinoma ofthe uterine cervix: An EORTC Gynecological Cancer Cooperative Group study

      ANNALS OF ONCOLOGY
    26. Khuri, FR; Herbst, RS; Fossella, FV
      Emerging therapies in non-small-cell lung cancer

      ANNALS OF ONCOLOGY
    27. Gebbia, V; Testa, A; Borsellino, N; Ferrera, P; Tirrito, M; Palmeri, S
      Cisplatin and vinorelbine in advanced and/or metastatic adenocarcinoma of the endometrium: A new highly active chemotherapeutic regimen

      ANNALS OF ONCOLOGY
    28. Oudard, S; Caty, A; Humblet, Y; Beauduin, M; Suc, E; Piccart, M; Rolland, F; Fumoleau, P; Bugat, R; Houyau, P; Monnier, A; Sun, X; Montcuquet, P; Breza, J; Novak, J; Gil, T; Chopin, D
      Phase II study of vinorelbine in patients with androgen-independent prostate cancer

      ANNALS OF ONCOLOGY
    29. Feliu, J; Martin, G; Lizon, J; Chacon, JI; Dorta, J; de Castro, J; Rodriguez, A; Heras, BS; Torrego, JC; Espinosa, E; Baron, MG
      Sequential therapy in advanced non-small-cell lung cancer with weekly paclitaxel followed by cisplatin-gemcitabine-vinorelbine. A phase II study

      ANNALS OF ONCOLOGY
    30. Jassem, J; Ramlau, R; Karnicka-Mlodkowska, H; Krawczyk, K; Krzakowski, M; Zatloukal, P; Lemarie, E; Hartmann, W; Novakova, L; O'Brien, M; Depierre, A
      A multicenter randomized phase II study of oral vs. intravenous vinorelbine in advanced non-small-cell lung cancer patients

      ANNALS OF ONCOLOGY
    31. Nole, F; Munzone, E; Mandala, M; Catania, C; Orlando, L; Zampino, MG; Minchella, I; Colleoni, M; Peruzzotti, G; Marrocco, E; Goldhirsch, A
      Vinorelbine, cisplatin and continuous infusion of 5-fluorouracil (ViFuP) in metastatic breast cancer patients: A phase II study

      ANNALS OF ONCOLOGY
    32. Leyland-Jones, B; Arnold, A; Gelmon, K; Verma, S; Ayoub, JP; Seidman, A; Dias, R; Howell, J; Rakhit, A
      Pharmacologic insights into the future of trastuzumab

      ANNALS OF ONCOLOGY
    33. Bonfante, V; Viviani, S; Devizzi, L; Di Russo, A; Di Nicola, M; Magni, M; Matteucci, P; Grisanti, S; Valagussa, P; Bonadonna, G; Gianni, AM
      High-dose ifosfamide and vinorelbine as salvage therapy for relapsed or refractory Hodgkin's disease

      EUROPEAN JOURNAL OF HAEMATOLOGY
    34. Natale, RB
      Gemcitabine and nonplatinum combinations in non-small-cell Lung cancer

      ONCOLOGY-NEW YORK
    35. Manegold, C
      Treatment of elderly patients with non-small-cell lung cancer

      ONCOLOGY-NEW YORK
    36. Hortobagyi, GN; Connally, NB
      Treatment of advanced breast cancer with gemcitabine and vinorelbine

      ONCOLOGY-NEW YORK
    37. Nagourney, RA
      Gemcitabine plus cisplatin in breast cancer

      ONCOLOGY-NEW YORK
    38. Ibrahim, NK; Valero, V; Rahman, Z; Theriault, RL; Walters, RS; Buzdar, AU; Booser, DJ; Holmes, FA; Murray, DJ; Willey, J; Bast, R; Hortobagyi, GN
      Phase I-II vinorelbine (Navelbine((R))) by continuous infusion in patientswith metastatic breast cancer: Cumulative toxicities limit dose escalation

      CANCER INVESTIGATION
    39. Burstein, HJ; Kuter, I; Campos, SM; Gelman, RS; Tribou, L; Parker, LM; Manola, J; Younger, J; Matulonis, U; Bunnell, CA; Partridge, AH; Richardson, PG; Clarke, K; Shulman, LN; Winer, EP
      Clinical activity of trastuzumab and vinorelbine in women with HER2-overexpressing metastatic breast cancer

      JOURNAL OF CLINICAL ONCOLOGY
    40. Zinzani, PL; Tani, M; Stefoni, V; Albertini, P; Bendandi, M; Gherlinzoni, F; Alinari, L; Vigna, E; Tura, S
      Efficacy of vinorelbine, epirubicin and prednisone combination regimen in pretreated elderly patients with aggressive non-Hodgkin's lymphoma

      HAEMATOLOGICA
    41. Malayeri, R; Pirker, R; Huber, H
      New drugs in the palliative chemotherapy of advanced non-small-cell lung cancer

      ONKOLOGIE
    42. Inoue, A; Saijo, N
      Recent advances in the chemotherapy of non-small cell lung cancer

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    43. Herbst, RS; Lynch, C; Vasconcelles, M; Teicher, BA; Strauss, G; Elias, A; Anderson, I; Zacarola, P; Dang, NH; Leong, T; Salgia, R; Skarin, AT
      Gemcitabine and vinorelbine in patients with advanced lung cancer: preclinical studies and report of a phase I trial

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    44. Ferrazzi, E; Toso, S; Zanotti, M; Giuliano, G
      Typhlitis (neutropenic enterocolitis) after a single dose of vinorelbine

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    45. Hegg, R; Costa, MA; Perdicaris, M; Delgado, GL; Cabral, S; Malzyner, A; Caponero, R; Yamagushi, N; Novaes, N; Anelli, A; Correa, M; Nader, L; Andrade, C
      A phase II trial of fractionated vinorelbine/doxorubicin as first-line therapy for advanced breast cancer

      CURRENT MEDICAL RESEARCH AND OPINION
    46. Karlsson, G; Nygren, P; Glimelius, B
      Economic aspects of chemotherapy

      ACTA ONCOLOGICA
    47. Long, TD; Twillman, RK; Cathers-Schiffman, TA; O'Donnell, T
      Treatment of vinorelbine-associated tumor pain

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    48. Fleming, GF; Waggoner, SE; Rotmensch, J; Langhauser, C
      Absence of major peripheral neuropathy in a phase II trial of ifosfamide with vinorelbine in patients with ovarian cancer previously treated with platinum and paclitaxel

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    49. Pectasides, D; Kalofonos, HP; Samantas, E; Nicolaides, C; Papacostas, P; Onyenadum, A; Visvikis, A; Skarlos, D; Fountzilas, G
      An out-patient second-line chemotherapy with gemcitabine and vinorelbine in patients with non-small cell lung cancer previously treated with cisplatin-based chemotherapy. A phase II study of the Hellenic Co-Operative Oncology Group

      ANTICANCER RESEARCH
    50. Locke, V; Davey, R; Davey, M
      Paclitaxel sensitization of multidrug-resistant cells to chemotherapy is independent of the cell cycle

      CYTOMETRY
    51. Montalar, J; Morales, S; Maestu, I; Camps, C; Vadell, C; Garcia, R; Yuste, AL; Torregrosa, D; Segura, A
      Vinorelbine, ifosfamide and cisplatin as first-line treatment in patients with inoperable non-small cell lung cancer

      LUNG CANCER
    52. Leu, KM; Kim, KM; Larson, M; Larson, M; Schiller, JH
      Phase I/II trial of docetaxel and vinorelbine in patients with non-small cell lung cancer previously treated with platinum-based chemotherapy

      LUNG CANCER
    53. Palmeri, S; Leonardi, V; Gebbia, V; De Bella, MT; Ferrau, F; Faillu, G; Spatafora, M; Valenza, R; Di Vita, G; Vitello, S; Carroccio, R; Sciortino, G; Vaglica, M; Accurso, V; Agostara, B; Licata, G
      Gemcitabine plus vinorelbine in stage IIIB or IV non-small cell lung cancer (NSCLC): a multicentre phase II clinical trial

      LUNG CANCER
    54. Kunitoh, H; Akiyama, Y; Kusaba, H; Yamamoto, N; Sekine, I; Ohe, Y; Kubota, K; Tamura, T; Shinkai, T; Kodama, T; Goto, K; Niho, S; Nishiwaki, Y; Saijo, N
      A phase I/II trial of cisplatin, docetaxel and ifosfamide in advanced or recurrent non-small cell lung cancer

      LUNG CANCER
    55. Gatzemeier, U
      Indications for chemotherapy in stage IV non-small cell lung cancer

      LUNG CANCER
    56. Horvath, L; Boyer, M; Clarke, S; Beale, P; Beith, J; Underhill, C; Stockler, M; Bishop, J
      Carboplatin and vinorelbine in untreated locally advanced and metastatic non-small cell lung cancer

      LUNG CANCER
    57. Kakolyris, S; Papadakis, E; Tsiafaki, X; Kalofonos, C; Rapti, A; Toubis, M; Bania, E; Kouroussis, C; Chainis, K; Androulakis, N; Agelaki, S; Sarra, E; Vardakis, N; Georgoulias, V
      Docetaxel in combination with gemcitabine plus rhG-CSF support as second-line treatment in non-small cell lung cancer. A multicenter phase II study

      LUNG CANCER
    58. De Pas, T; de Braud, F; Mandala, M; Curigliano, G; Catania, C; Ferretti, G; Sozzi, P; Solli, P; Goldhirsch, A
      Cisplatin and vinorelbine as second-line chemotherapy in patients with advanced non-small cell lung cancer (NSCLC) resistant to taxol plus gemcitabine

      LUNG CANCER
    59. Gridelli, C; Cigolari, S; Gallo, C; Manzione, L; Ianniello, GP; Frontini, L; Ferrau, F; Robbiati, SF; Adamo, V; Gasparini, G; Novello, S; Perrone, F
      Activity and toxicity of gemcitabine and gemcitabine plus vinorelbine in advanced non-small-cell lung cancer elderly patients - Phase II data from the Multicenter Italian Lung Cancer in the Elderly Study (MILES) randomized trial

      LUNG CANCER
    60. Breton, JL; Westeel, V; Jacoulet, P; Mercier, M; Chazard, M; Depierre, A
      Phase I study of paclitaxel (Taxol (R)) plus vinorelbine (Navelbine (R)) in patients with untreated stage IIIb and IV non-small cell lung cancer

      LUNG CANCER
    61. Mariani, G; Tagliabue, P; Zucchinelli, P; Brambilla, C; Demicheli, R; Villa, E; Marchiano, A; Valagussa, P; Bonadonna, G; Gianni, L
      Phase I/II study of gemcitabine in association with vinorelbine for metastatic breast cancer

      BREAST CANCER RESEARCH AND TREATMENT
    62. Konecny, G; Untch, M; Slamon, D; Beryt, M; Kahlert, S; Felber, M; Langer, E; Lude, S; Hepp, H; Pegram, M
      Drug interactions and cytotoxic effects of paclitaxel in combination with carboplatin, epirubicin, gemcitabine or vinorelbine in breast cancer cell lines and tumor samples

      BREAST CANCER RESEARCH AND TREATMENT
    63. Smorenburg, CH; Bontenbal, M; Seynaeve, C; van Zuylen, C; de Heus, G; Verweij, J; de Wit, R
      Phase II study of weekly gemcitabine in patients with metastatic breast cancer relapsing or failing both an anthracycline and a taxane

      BREAST CANCER RESEARCH AND TREATMENT
    64. Lynch, TJ
      Review of two phase III randomized trials of single-agent docetaxel in previously treated advanced non-small cell lung cancer

      SEMINARS IN ONCOLOGY
    65. Gandara, DR; Lara, PN; Goldberg, Z; Lau, DHM
      Integration of new chemotherapeutic agents into chemoradiotherapy for stage III non-small cell lung cancer: Focus on docetaxel

      SEMINARS IN ONCOLOGY
    66. Frasci, G; D'Aiuto, G; Comella, P; Thomas, R; Capasso, I; Botti, G; Cortino, GR; De Rosa, V; Comella, G
      Gemcitabine/cyclophosphamide/5-fluorouracil/folinic acid triplet combination in anthracycline- and taxane-refractory breast cancer patients: A southern Italy cooperative oncology group phase I/II study

      SEMINARS IN ONCOLOGY
    67. Manegold, C
      Chemotherapy for advanced non-small cell lung cancer

      SEMINARS IN ONCOLOGY
    68. Hensley, ML; Hoppe, B; Leon, L; Sabbatini, P; Aghajanian, C; Chi, D; Spriggs, DR
      The costs and efficacy of liposomal doxorubicin in platinum-refractory ovarian cancer in heavily pretreated patients

      GYNECOLOGIC ONCOLOGY
    69. Sorensen, P; Hoyer, M; Jakobsen, A; Malmstrom, H; Havsteen, H; Bertelsen, K
      Phase II study of vinorelbine in the treatment of platinum-resistant ovarian carcinoma

      GYNECOLOGIC ONCOLOGY
    70. Bianco, V; Di Girolamo, B; Pignatelli, E; Speranza, I; Florio, G; Gemma, D; Girolami, M; Vietri, F; Marchei, P
      Gemcitabine as single agent therapy in advanced non small cell lung cancerand quality of life in the elderly

      PANMINERVA MEDICA
    71. Janne, PA; Rodriguez-Thompson, D; Metcalf, DR; Swanson, SJ; Greisman, HA; Wilkins-Haug, L; Johnson, BE
      Chemotherapy for a patient with advanced non-small-cell lung cancer duringpregnancy: A case report and a review of chemotherapy treatment during pregnancy

      ONCOLOGY
    72. Winer, EP; Burstein, HJ
      New combinations with Herceptin((R)) in metastatic breast cancer

      ONCOLOGY
    73. Schiller, JH
      Current standards of care in small-cell and non-small-cell lung cancer

      ONCOLOGY
    74. Stupp, R; Bodmer, A; Duvoisin, B; Bauer, J; Perey, L; Bakr, M; Ketterer, N; Leyvraz, S
      Is cisplatin required for the treatment of non-small-cell lung cancer? Experience and preliminary results of a phase I/II trial with topotecan and vinorelbine

      ONCOLOGY
    75. Agelaki, S; Bania, H; Kouroussis, C; Blazoyiannakis, G; Sougalkos, J; Tsiafaki, X; Harpidou, A; Kalbakis, K; Rapti, A; Androulakis, N; Sarra, E; Georgoulias, V; Papadakis, E
      Vinorelbine-based regimens as salvage treatment in patients with advanced non-small cell lung cancer: Two parallel multicenter phase II trials

      ONCOLOGY
    76. Vici, P; Belli, F; Di Lauro, L; Amodio, A; Conti, F; Foggi, P; Gionfra, T; Morelli, MF; Botti, C; Ferraironi, A; Lopez, M
      Docetaxel in patients with anthracycline-resistant advanced breast cancer

      ONCOLOGY
    77. Zelek, L; Barthier, S; Riofrio, M; Fizazi, K; Rixe, O; Delord, JP; Le Cesne, A; Spielmann, M
      Weekly vinorelbine is an effective palliative regimen after failure with anthracyclines and taxanes in metastatic breast carcinoma

      CANCER
    78. Hainsworth, JD; Burris, HA; Billings, FT; Bradof, JE; Baker, M; Greco, FA
      Weekly docetaxel with either gemcitabine or vinorelbine as second-line treatment in patients with advanced nonsmall cell lung carcinoma - Phase II trials of the Minnie Pearl Cancer Research Network

      CANCER
    79. Hirsh, V; Langleben, A; Ayoub, J; Cormier, Y; Pintos, J; Iglesias, JL
      Flexible chemotherapy regimen with gemcitabine and vinorelbine for metastatic nonsmall cell lung carcinoma - A phase II multicenter trial

      CANCER
    80. Kosmas, C; Tsavaris, N; Vadiaka, M; Stavroyianni, N; Koutras, A; Malamos, N; Onyenadum, A; Rokana, S; Polyzos, A; Kalofonos, HP
      Gemcitabine and docetaxel as second-line chemotherapy for patients with nonsmall cell lung carcinoma who fail prior paclitaxel plus platinum-based regimens

      CANCER
    81. Sweeney, CJ; Zhu, JM; Sandler, AB; Schiller, J; Belani, CP; Langer, C; Krook, J; Harrington, D; Johnson, DH
      Outcome of patients with a performance status of 2 in Eastern cooperative oncology group study E1594 - A phase III trial in patients with metastatic nonsmall cell lung carcinoma

      CANCER
    82. Ibrahim, NK; Buzdar, AU; Valero, V; Dhingra, K; Willey, J; Hortobagyi, GN
      Phase I study of vinorelbine and paclitaxel by 3-hour simultaneous infusion with and without granulocyte colony-stimulating factor support in metastatic breast carcinoma

      CANCER
    83. Airoldi, M; Pedani, F; Succo, G; Gabriele, AM; Ragona, R; Marchionatti, S; Bumma, C
      Phase II randomized trial comparing vinorelbine versus vinorelbine plus cisplatin in patients with recurrent salivary gland malignancies

      CANCER
    84. Liu, XM; Wang, LG; Kreis, W; Budman, DR; Adams, LM
      Differential effect of vinorelbine versus paclitaxel on ERK2 kinase activity during apoptosis in MCF-7 cells

      BRITISH JOURNAL OF CANCER
    85. Ferguson, J
      Evaluating new treatments for advanced cancer - Reply

      BRITISH JOURNAL OF CANCER
    86. Holwell, SE; Bill, BT; Bibby, MC
      Anti-vascular effects of vinflunine in the MAC 15A transplantable adenocarcinoma model

      BRITISH JOURNAL OF CANCER
    87. Leonard, RCF
      Oval fluoropyrimidines among the new drugs for patients with metastatic breast cancer

      BRITISH JOURNAL OF CANCER
    88. Van Heugen, JC; De Graeve, J; Zorza, G; Puozzo, C
      New sensitive liquid chromatography method coupled with tandem mass spectrometric detection for the clinical analysis of vinorelbine and its metabolites in blood, plasma, urine and faeces

      JOURNAL OF CHROMATOGRAPHY A
    89. Gauvin, AL; Pinguet, F; Poujol, S; Astre, C; Bressolle, F
      High-performance liquid chromatographic determination of vinorelbine in human plasma and blood: application to a pharmacokinetic study

      JOURNAL OF CHROMATOGRAPHY B
    90. Dumontet, C
      Mechanisms of action and resistance to tubulin-binding agents

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    91. Gauvin, A; Pinguet, F; Culine, S; Astre, C; Gomeni, R; Bressolle, F
      Bayesian estimate of vinorelbine pharmacokinetic parameters in elderly patients with advanced metastatic cancer

      CLINICAL CANCER RESEARCH
    92. Kraus-Berthier, L; Jan, M; Guilbaud, N; Naze, M; Pierre, A; Atassi, G
      Histology and sensitivity to anticancer drugs of two human non-small cell lung carcinomas implanted in the pleural cavity of nude mice

      CLINICAL CANCER RESEARCH
    93. Reif, MS; Rivera, MP
      Evidence-based outcomes for patients with advanced non-small cell lung cancer

      SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
    94. Sarris, AH; Psyrri, A; Hagemeister, F; Romaguera, J; McLaughlin, P; Rodriguez, MA; Bachier, C; Younes, A; Mesina, O; Oholendt, M; Medeiros, LJ; Samuels, B; Adams, LM; Cabanillas, F
      Infusional vinorelbine in relapsed or refractory lymphomas

      LEUKEMIA & LYMPHOMA
    95. Gridelli, C
      Chemotherapy of advanced non small cell lung cancer in the elderly: an update

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    96. Udom, DI; Vigushin, DM; Linardou, H; Graham, H; Palmieri, C; Coombes, RC
      Two weekly vinorelbine: administration in patients who have received at least two prior chemotherapy regimes for advanced breast cancer

      EUROPEAN JOURNAL OF CANCER
    97. Lhomme, C; Vermorken, JB; Mickiewicz, E; Chevalier, B; Alvarez, A; Mendiola, C; Pawinski, A; Lentz, MA; Pecorelli, S
      Phase II trial of vinorelbine in patients with advanced and/or recurrent cervical carcinoma: an EORTC Gynaecological Cancer Cooperative Group Study

      EUROPEAN JOURNAL OF CANCER
    98. Schmidinger, M; Steger, GG; Budinsky, AC; Wenzel, C; Brodowicz, T; Locker, GJ; Kramer, G; Marberger, M; Zielinski, CC
      Vinorelbine and interferon-alpha 2c as second-line therapy in metastatic renal cell carcinoma

      ANTI-CANCER DRUGS
    99. Vassilomanolakis, M; Koumakis, G; Barbounis, V; Demiri, M; Pateras, H; Efremidis, AP
      Vinorelbine and cisplatin in metastatic breast cancer patients previously treated with anthracyclines

      ANNALS OF ONCOLOGY
    100. Krajnik, G; Mohn-Staudner, A; Thaler, J; Greil, R; Schmeikal, S; Marhold, F; Deutsch, J; Preiss, P; Malayeri, R; Schafer-Prokop, C; Wein, W; Huber, H; Pirker, R
      Vinorelbine-gemcitabine in advanced non-small-cell lung cancer (NSCLC): AnAASLC phase II trial

      ANNALS OF ONCOLOGY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/10/20 alle ore 23:03:38